{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:55:16Z","timestamp":1788839716146,"version":"build-2803163510"},"reference-count":28,"publisher":"Japanese Circulation Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2023,2,10]]},"DOI":"10.1253\/circrep.cr-22-0091","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T22:09:27Z","timestamp":1674079767000},"page":"27-37","source":"Crossref","is-referenced-by-count":5,"title":["Real-World Intravenous Diuretic Use to Treat Congestion in Patients With Heart Failure\u3000\u2015 An Observational Study Using a Research Database \u2015"],"prefix":"10.1253","volume":"5","author":[{"given":"Yasuyuki","family":"Shiraishi","sequence":"first","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Kurita","sequence":"additional","affiliation":[{"name":"Medical Affairs, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Matsukawa","sequence":"additional","affiliation":[{"name":"Medical Affairs, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Mori","sequence":"additional","affiliation":[{"name":"Medical Affairs, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. <i>Eur Heart J<\/i> 2021; 42: 3599\u20133726, doi:10.1093\/eurheartj\/ehab368.","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Verbrugge FH. Editor\u2019s choice-diuretic resistance in acute heart failure. <i>Eur Heart J Acute Cardiovasc Care<\/i> 2018; 7: 379\u2013389, doi:10.1177\/2048872618768488.","DOI":"10.1177\/2048872618768488"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Tsutsui H, Isobe M, Ito H, Ito H, Okumura K, Ono M, et al. JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure: Digest version. <i>Circ J<\/i> 2019; 83: 2084\u20132184, doi:10.1253\/circj.CJ-19-0342.","DOI":"10.1253\/circj.CJ-19-0342"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart disease and stroke statistics \u2013 2021 update: A report from the American Heart Association. <i>Circulation<\/i> 2021; 143: e254\u2013e743, doi:10.1161\/CIR.0000000000000950.","DOI":"10.1161\/CIR.0000000000000950"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Akita K, Kohno T, Kohsaka S, Shiraishi Y, Nagatomo Y, Goda A, et al. Prognostic impact of previous hospitalization in acute heart failure patients. <i>Circ J<\/i> 2019; 83: 1261\u20131268, doi:10.1253\/circj.CJ-18-1087.","DOI":"10.1253\/circj.CJ-18-1087"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Arrigo M, Jessup M, Mullens W, Reza N, Shah AM, Sliwa K, et al. Acute heart failure. <i>Nat Rev Dis Primers<\/i> 2020; 6: 16, doi:10.1038\/s41572-020-0151-7.","DOI":"10.1038\/s41572-020-0151-7"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Filippatos G, Angermann CE, Cleland JGF, Lam CSP, Dahlstr\u00f6m U, Dickstein K, et al. Global differences in characteristics, precipitants, and initial management of patients presenting with acute heart failure. <i>JAMA Cardiol<\/i> 2020; 5: 401\u2013410, doi:10.1001\/jamacardio.2019.5108.","DOI":"10.1001\/jamacardio.2019.5108"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Matsue Y, Damman K, Voors AA, Kagiyama N, Yamaguchi T, Kuroda S, et al. Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure. <i>J Am Coll Cardiol<\/i> 2017; 69: 3042\u20133051, doi:10.1016\/j.jacc.2017.04.042.","DOI":"10.1016\/j.jacc.2017.04.042"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Mullens W, Damman K, Harjola VP, Mebazaa A, Brunner-La Rocca HP, Martens P, et al. The use of diuretics in heart failure with congestion: A position statement from the Heart Failure Association of the European Society of Cardiology. <i>Eur J Heart Fail<\/i> 2019; 21: 137\u2013155, doi:10.1002\/ejhf.1369.","DOI":"10.1002\/ejhf.1369"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Shiraishi Y, Kawana M, Nakata J, Sato N, Fukuda K, Kohsaka S. Time-sensitive approach in the management of acute heart failure. <i>ESC Heart Fail<\/i> 2021; 8: 204\u2013221, doi:10.1002\/ehf2.13139.","DOI":"10.1002\/ehf2.13139"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. <i>PLoS Med<\/i> 2007; 4: e296, doi:10.1371\/journal.pmed.0040296.","DOI":"10.1371\/journal.pmed.0040296"},{"key":"12","unstructured":"12. Medical Data Vision. Press release: Overview of claims database in September 2021 [in Japanese]. https:\/\/www.mdv.co.jp\/press\/2021\/detail_1594.html (accessed March 1, 2021)."},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Desai AS, Stevenson LW. Rehospitalization for heart failure: Predict or prevent? <i>Circulation<\/i> 2012; 126: 501\u2013506, doi:10.1161\/CIRCULATIONAHA.112.125435.","DOI":"10.1161\/CIRCULATIONAHA.112.125435"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Shiraishi Y, Kohsaka S, Sato N, Takano T, Kitai T, Yoshikawa T, et al. 9-year trend in the management of acute heart failure in Japan: A report from the National Consortium of Acute Heart Failure Registries. <i>J Am Heart Assoc<\/i> 2018; 7: e008687, doi:10.1161\/JAHA.118.008687.","DOI":"10.1161\/JAHA.118.008687"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Kitakata H, Kohno T, Kohsaka S, Shiraishi Y, Parizo JT, Niimi N, et al. Prognostic implications of early and midrange readmissions after acute heart failure hospitalizations: A report from a Japanese multicenter registry. <i>J Am Heart Assoc<\/i> 2020; 9: e014949, doi:10.1161\/JAHA.119.014949.","DOI":"10.1161\/JAHA.119.014949"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mahoney FI, Barthel DW. Functional evaluation: The Barthel Index. <i>Md State Med J<\/i> 1965; 14: 61\u201365.","DOI":"10.1037\/t02366-000"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Ide T, Kaku H, Matsushima S, Tohyama T, Enzan N, Funakoshi K, et al. Clinical characteristics and outcomes of hospitalized patients with heart failure from the large-scale Japanese Registry Of Acute Decompensated Heart Failure (JROADHF). <i>Circ J<\/i> 2021; 85: 1438\u20131450, doi:10.1253\/circj.CJ-20-0947.","DOI":"10.1253\/circj.CJ-20-0947"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Chen L, Ionescu-Ittu R, Romdhani H, Guerin A, Kessler P, Borentain M, et al. Disease management and outcomes in patients hospitalized for acute heart failure in Japan. <i>Cardiol Ther<\/i> 2021; 10: 211\u2013228, doi:10.1007\/s40119-021-00212-y.","DOI":"10.1007\/s40119-021-00212-y"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Shiraishi Y, Kohsaka S, Abe T, Mizuno A, Goda A, Izumi Y, et al. Validation of the get with the guideline-heart failure risk score in Japanese patients and the potential improvement of its discrimination ability by the inclusion of B-type natriuretic peptide level. <i>Am Heart J<\/i> 2016; 171: 33\u201339, doi:10.1016\/j.ahj.2015.10.008.","DOI":"10.1016\/j.ahj.2015.10.008"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Komuro J, Nagatomo Y, Mahara K, Isobe M, Goda A, Sujino Y, et al. Clinical scenario classification for characterization and outcome prediction of acute decompensated heart failure under contemporary phenotyping. <i>Circ Rep<\/i> 2019; 1: 162\u2013170, doi:10.1253\/circrep.CR-18-0013.","DOI":"10.1253\/circrep.CR-18-0013"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Hirai M, Kato M, Kinugasa Y, Sugihara S, Yanagihara K, Yamada K, et al. Clinical scenario 1 is associated with winter onset of acute heart failure. <i>Circ J<\/i> 2015; 79: 129\u2013135, doi:10.1253\/circj.CJ-14-0710.","DOI":"10.1253\/circj.CJ-14-0710"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Peacock WF, Emerman C, Costanzo MR, Diercks DB, Lopatin M, Fonarow GC. Early vasoactive drugs improve heart failure outcomes. <i>Congest Heart Fail<\/i> 2009; 15: 256\u2013264, doi:10.1111\/j.1751-7133.2009.00112.x.","DOI":"10.1111\/j.1751-7133.2009.00112.x"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Sato N, Kajimoto K, Keida T, Mizuno M, Minami Y, Yumino D, et al. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry). <i>Circ J<\/i> 2013; 77: 944\u2013951, doi:10.1253\/circj.cj-13-0187.","DOI":"10.1253\/circj.CJ-13-0187"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Maisel AS, Peacock WF, McMullin N, Jessie R, Fonarow GC, Wynne J, et al. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: An ADHERE (Acute Decompensated Heart Failure National Registry) analysis. <i>J Am Coll Cardiol<\/i> 2008; 52: 534\u2013540, doi:10.1016\/j.jacc.2008.05.010.","DOI":"10.1016\/j.jacc.2008.05.010"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Harjola VP, Mullens W, Banaszewski M, Bauersachs J, Brunner-La Rocca HP, Chioncel O, et al. Organ dysfunction, injury and failure in acute heart failure: From pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). <i>Eur J Heart Fail<\/i> 2017; 19: 821\u2013836, doi:10.1002\/ejhf.872.","DOI":"10.1002\/ejhf.872"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Greene SJ, Triana TS, Ionescu-Ittu R, Burne RM, Gu\u00e9rin A, Borentain M, et al. In-hospital therapy for heart failure with reduced ejection fraction in the United States. <i>JACC Heart Fail<\/i> 2020; 8: 943\u2013953, doi:10.1016\/j.jchf.2020.05.013.","DOI":"10.1016\/j.jchf.2020.05.013"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Yamazaki Y, Shiraishi Y, Kohsaka S, Nagatomo Y, Fukuda K, Kohno T, et al. Temporal trends in tolvaptan use after revision of national heart failure guidelines in Japan. <i>Sci Rep<\/i> 2021; 11: 19360, doi:10.1038\/s41598-021-98173-8.","DOI":"10.1038\/s41598-021-98173-8"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Oguri M, Ishii H, Takahara K, Yasuda K, Takikawa T, Sumi T, et al. Efficacy of rapid decongestion strategy in patients hospitalized for acute heart failure. <i>Circ J<\/i> 2020; 84: 958\u2013964, doi:10.1253\/circj.CJ-19-1128.","DOI":"10.1253\/circj.CJ-19-1128"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/5\/2\/5_CR-22-0091\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T03:18:55Z","timestamp":1676085535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/5\/2\/5_CR-22-0091\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-22-0091","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,10]]},"article-number":"CR-22-0091"}}